NL
Nuclein, LLC
SEC filingBiotechnology · Austin, TX
Amount raised$9.3Msold at filing
Total offering$16.1M$6.9M still open
Investors in the raise15count reported to the SEC
FiledAug 14, 2026first sale Jun 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Douglas BryantDirector
Walter David NarajowskiDirector
Sanjay ChandraDirector
Alan BlakeExecutive Officer, Director
Jeffrey David StukulsExecutive Officer
Richard CrockettDirector
William CunninghamDirector
H. David ShockleyDirector
Executive officers, directors and promoters as listed on the Form D.